Recent insider trading activity from Roberts Brandi, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2026 | Definium Therapeutics, Inc. | $DFTX | Roberts Brandi | Chief Financial Officer | A | Common Shares | 150000 | $0.00 | 150,000.0000 | 98,509,279 | 9999.99% | 0.15% |
| June 2, 2025 | Definium Therapeutics, Inc. | $DFTX | Roberts Brandi | Chief Financial Officer | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 75,368,359 | 9999.99% | 0.66% |